Psychiatric disorders in temporal lobe epilepsy: An overview from a tertiary service in Brazil  by de Oliveira, Guilherme Nogueira M. et al.
Seizure 19 (2010) 479–484Psychiatric disorders in temporal lobe epilepsy:
An overview from a tertiary service in Brazil
Guilherme Nogueira M. de Oliveira a,b,c,**, Arthur Kummer a, Joa˜o Vinı´cius Salgado a,
Eduardo Jardel Portela a, Sı´lvio Roberto Sousa-Pereira a, Anthony S. David c, Antoˆnio Lu´cio Teixeira a,*
aNeuropsychiatric Unit, Neurology Division, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
bDepartment of Mental Health, University Centre of Belo Horizonte, Uni-BH, Brazil
c Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King’s College London, DeCrespigny Park, London SE5 8AF, United Kingdom
A R T I C L E I N F O
Article history:
Received 28 April 2010
Received in revised form 30 June 2010
Accepted 9 July 2010
Keywords:
Temporal lobe epilepsy
Mesial temporal sclerosis
Psychiatric disorders
Depression
Anxiety
A B S T R A C T
Purpose: To evaluate the frequency and intensity of psychiatric disorders in a group of temporal lobe
epilepsy (TLE) patients from a tertiary-care center.
Methods: Clinical and sociodemographic data of 73 patients were collected and a neuropsychiatric
evaluation was performed with the following instruments: Mini-Mental State Examination (MMSE),
structured clinical interview (MINI-PLUS), Hamilton Anxiety Scale (HAM-A), Hamilton Depression Scale
(HAM-D), Brief Psychiatric Rating Scale (BPRS).
Results: Patients with TLE showed a high frequency of lifetime psychiatric disorders (70%), the most
frequent being mood disorders (49.3%). At assessment, 27.4% of the patients were depressed and 9.6%
met criteria for bipolar disorder. Nevertheless, depression had not been properly diagnosed nor treated.
Anxiety disorders were also frequent (42.5%), mainly generalized anxiety disorder (GAD) (21.9%).
Obsessive compulsive disorder (OCD)was present in 11.0% and psychotic disorders in 5.5% of the sample.
Patients with left mesial temporal sclerosis (LMTS) exhibited more psychopathologic features, mainly
anxiety disorders (p = 0.006), and scored higher on HAM-A and HAM-D (p < 0.05 in both).
Conclusion: TLE is related to a high frequency of psychiatric disorders, such as anxiety and depression,
which are usually underdiagnosed and undertreated. Damage to the left mesial temporal lobe, seen in
LMTS, seems to be an important pathogenic lesion linked to a broad range of psychopathological features
in TLE, mainly anxiety disorders. The present study prompts discussion on the recognition of the
common psychiatric disorders in TLE, especially on the Brazilian setting.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Mental disorders are very common in epilepsy and may even
precede the onset of seizures. Studies have shown a high
prevalence of epilepsy in individuals with mental disorders,
suggesting an association between the two conditions.1–3 Such
connection was observed in a recent epidemiological study in a
psychiatric hospital where 10% of the inpatients had epilepsy.1
Further, several other studies report a high prevalence of
psychiatric disorders in people with epilepsy.4–6 Despite the lack* Corresponding author at: Departamento de Clı´nica Me´dica, Faculdade de
Medicina, UFMG. 30130-100 Av. Prof. Alfredo Balena, 190 Santa Eﬁgeˆnia, Belo
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** Corresponding author at: Section of Cognitive Neuropsychiatry, Institute of
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1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.07.004of epidemiologic data in Brazil, it is estimated that there is
something between 530 thousand and 890 thousand people with
epilepsy and some associated mental disorders in this country.7
Temporal lobe epilepsy (TLE) encompasses epileptic syndromes
that arise in the temporal lobes and mesial temporal lobe epilepsy
(MTLE), the main subtype of TLE, is probably the commonest
presentation of epilepsy in humans.8–10 MTLE is frequently
associated with a poor seizure response to antiepileptic drugs
(AEDs), especially if mesial temporal sclerosis (MTS) is present.9,11
MTLE is also called limbic epilepsy and the latter term has been
preferred by many authors because it reinforces the idea of a
system involvement rather than speciﬁc structures.10 In addition,
studies have emphasized that patients with TLE present a high
propensity to develop psychiatric disorders due to the role of the
limbic system in regulating emotions, mood and behavior.12–15
It should be noted that it is difﬁcult to establish precisely the
frequencyofpsychiatricdisorders inepilepsy, asmentalphenomena
may result from a complex interaction between neurophysiologic
changes caused by seizures, AEDs side effects, individual vulnera-vier Ltd. All rights reserved.
Table 1
Sociodemographic and clinical characteristics of the study sample.
Patients (n=73)
n or mean (SD) Proportion
(%) or median
(range)
Gender
Male 34 46.6%
Female 39 53.4%
Age (years) 42.2 (10.0) 43 (21–65)
Ethnic group
White 34 46.6%
Black 9 12.3%
‘‘Pardo’’a 30 41.1%
Educational level,
years of study
6.9 (3.5) 6 (0–12)
Marital statusb
Single 29 40.3%
Married/stable union 28 38.9%
Divorced/separate 11 15.3%
Widowed 4 5.6%
Employment situation
Employed 31 42.5%
Unemployed 10 13.7%
Retired (age or time
of service purposes)
6 8.2%
Retired (due to illness) 26 35.6%
Seizure type
Simple partial 31 42.5%
Complex partial 70 95.9%
Partial evolving to
secondarily generalized
28 38.4%
Age at onset of epilepsy (years) 8.5 (9.8) 5 (0–49)
Duration of epilepsy (years) 33.7 (12.2) 34 (3–54)
Seizure frequency, seizures
per month
4.8 (7.6) 2 (0–40)
Refractory epilepsy 59 80.8%
Seizure free for six
months or longer
7 9.6%
MRI
WMTS 10 13.7%
RMTS 25 34.2%
LMTS 30 41.1%
BMTS 8 11%
AEDs therapy regime (%)
Monotherapy 9 12.3%
Dualtherapy 47 64.4%
3 AEDs 17 23.3%
SD, standard deviation; MRI, magnetic resonance imaging; WMTS, without MTS;
RMTS, right mesial temporal sclerosis; LMTS, left mesial temporal sclerosis; BMTS,
bilateral MTS; AEDs, antiepileptic drugs.
a ‘‘Pardo’’: mixed race or color (mulato, mestizo).
b One patient failed to disclose marital status.
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therefore, challenging to diagnose, treat, minimize functional
impairment and improve quality of life of these patients.2 In this
studyweconductedapsychiatric survey ina groupofTLEpatients in
a tertiary-care service in Brazil and we describe and correlate their
psychopathological, sociodemographic and clinical characteristics.
2. Methods
A cross-sectional study was conducted with 73 TLE patients. All
subjects were monitored by the Epilepsy Clinic of the Neurology
Service, Hospital das Clı´nicas, Universidade Federal de Minas
Gerais (UFMG), which is a regional reference service for refractory
epilepsy treatment. This service encompasses around 1000
patients that are referred from general practitioners, general
physicians, or general neurologists of the whole state of Minas
Gerais due to difﬁcult control of seizures. This study was approved
by the local Ethics Committee (according to the Declaration of
Helsinki). The inclusion criteria were: diagnosis of TLE according to
the ILAE criteria,8 age more than 18 years and capacity to provide
written informed consent for participation in the study. Patients
were excluded if they had severe medical or neurologic disease
other than epilepsy, history of previous neurosurgery, and severe
cognitive impairment according to MMSE performance.19
Sociodemographic (age, gender, ethnicity, marital status,
employment situation and educational level) and clinical informa-
tion (age at onset and duration of the epilepsy, seizure type, seizure
frequency, refractory epilepsy according to ILAE criteria,20
antiepileptic drug regime, MRI and EEG ﬁndings) were collected.
Psychiatric diagnosis was made according to the Mini
International Neuropsychiatric Interview (MINI) Plus version
5.0.0. The MINI-PLUS is an internationally validated standardized
interview frequently used in clinical and research contexts,
following DSM-IV and ICD-10 criteria.21–23 Algorithms are
integrated into the structure of the questionnaire and they allow
hierarchical diagnosis as well as psychiatric comorbidities in the
same patient.21 For psychiatric diagnosis the recommendations of
ILAE Commission on Psychobiology of Epilepsy were also followed
in order to conduct a more descriptive classiﬁcation, correlating
clinical variables (e.g., ictal and interictal symptoms, relationship
with AEDs therapy, etc.) and avoiding pre-setting all cases with an
‘‘organic’’ etiologic label.24,25 Patients who met diagnostic criteria
for clinically signiﬁcant mental disorders were referred for
psychiatric treatment. Anxiety symptoms were assessed using
the Hamilton Anxiety Scale (HAM-A) (total score range: 0–
56).24,26,27 Hamilton Depression Scale (HAM-D)24,28,29 was used
to measure depressive symptoms. We used the 24-item HAM-D
(total score range: 0–75), which includes helplessness, hopeless-
ness and low self-esteem items,29 in order to reduce the weight of
the somatic symptoms, increasing its speciﬁcity. The 18-item Brief
Psychiatric Rating Scale (BPRS) (total score range: 0–108) was used
to quantify psychotic and general psychopathology.30,31
Descriptiveanalysis of categorical variables andproportionswere
calculated and presented. For comparison of categorical variables
between groups Fisher’s Exact test was performed and continuous
variableswereevaluatedusing theKruskal–Wallis test.All testswere
performed using SPSS version 15.0 for Windows. A lower than 0.05
two-sided p-value was considered signiﬁcant for all tests.
3. Results
3.1. Clinical and sociodemographic characteristics
Seventy-three patients were included in this study. The
sociodemographic and clinical characteristics of patients with
TLE are displayed in Table 1.Patients had a mean of 4.8 seizures per month, usually with
childhood onset (mean age 8.5 years) and long time course (mean
33.7 years). A combination of focal seizures types was observed as
95.9% exhibited complex partial, 42.5% had simple partial seizures
and secondarily generalization was reported in 28 individuals
(38.4%). It is worth noting the impairment on working capacity
where less than half (42.5%) of the patients were employed.
Most of the patients (64.4%) were on two AEDs. Carbamazepine
(64.4%) in monotherapy or in association with other drugs was the
most prescribed AED alone; benzodiazepines (72.6%) were the
most common pharmacological group.
Refractoriness was characterized in the majority of patients
(80.8%) and only a few had achieved seizure control for more than
six months.
Table 2
Frequency of psychiatric disorders in temporal lobe epilepsy patients according to
the MINI-PLUS (note patients may have more than one diagnosis).
Psychiatric disorder Patients (n=73)
N Proportion (%)
Any disorder (current) 43 58.9%
Any disorder (lifetime) 51 69.9%
Any mood disorder (lifetime) 36 49.3%
Bipolar disorder (BD) 7 9.6%
BD – maniac episode 3 4.1%
BD – hipomaniac episode 4 5.5%
Major depressive episode (lifetime) 27 37.0%
Major depressive episode (current) 20 27.4%
Major depressive disorder (current) 16 21.9%
BD – depressive episode (current) 4 5.5%
Dysthymia 2 2.7%
Any anxiety disorder 31 42.5%
Panic disorder 10 13.7%
Agoraphobia 13 17.8%
Social phobia 11 15.1%
Simple phobia 9 12.3%
Generalized anxiety disorder (GAD) 16 21.9%
Mixed anxiety–depression disorder 1 1.4%
Obsessive compulsive disorder (OCD) 8 11.0%
Any psychosis 4 5.5%
Psychosis NOS 1 1.4%
Schizophrenia 3 4.1%
Somatoform disorder 10 13.7%
Hypochondriac disorder 1 1.4%
Body dysmorphic disorder 2 2.7%
Pain disorder 7 9.6%
Attention-deﬁcit/hyperactivity
disorder (ADHD)
2 2.7%
Premenstrual dysphoric
disorder (PMDD)a
9 34.6%
a Premenopausal women=26.
G.N.M. de Oliveira et al. / Seizure 19 (2010) 479–484 4813.2. Psychiatric characteristics
Table 2 lists the neuropsychiatric comorbidities demonstrating
the high frequency of lifetime psychiatric disorders (69.9%),
especially mood disorders (49.3%).
Only one patient (6.3%) diagnosed with major depressive
disorder was taking antidepressants and scored 33 on the HAM-D.Table 3
Demographic and clinical characteristics of the study sample according to mesial temp
Total (n=73)
RMTS (n=25) LMT
Sex
Female; n (%) 12 (48%) 21 (
Mean age, years (SD) 41.4 (10.1) 44.2
Ethnic group
‘‘Pardo’’a; n (%) 10 (40%) 9 (
Marital statusb
Married; n (%) 9 (37.5%) 15 (
Employment status
Employed; n (%) 12 (48%) 12 (
Seizure type
Simple partial 12 (48%) 10 (
Complex partial 24 (96%) 28 (
Partial evolving to secondarily generalized 6 (24%) 13 (
Mean time since seizures onset, years (SD) 29.8 (9.1) 35.9
Mean frequency, seizures/month (SD) 6.3 (9.5) 3.1
Refractory epilepsy; n (%) 21 (84%) 25 (
Seizure free for the last six months; n (%) 2 (8%) 2 (
Mean number AEDs per patient (SD) 2.0 (0.7) 2.1
Currently taking antidepressants; n (%) 2 (8%) 3 (
WMTS, without MTS; RMTS, right mesial temporal sclerosis; LMTS, left mesial tempora
a ‘‘Pardo’’: mixed race or color (mulato, mestizo).
b One patient failed to disclose marital status.
* Fisher’s Exact test.
** Kruskal–Wallis test.It was possible to identify ictal and perictal psychotic symptoms
in only one patient. This patient also met criteria for the diagnosis
of schizophrenia due to the interictal psychotic state (BPRS = 28).
Only one other patient in the psychotic group, diagnosed with
schizophrenia, was on antipsychotic medication (risperidone
4 mg/d) and presented mild psychotic symptoms (BPRS = 30).
The other patient diagnosed with schizophrenia diagnosis scored
47 points in the BPRS and the one with psychosis NOS, 8 points.
There were no signiﬁcant differences regarding refractoriness
and the presence of any mental disorder.
3.3. Characteristics and frequency of psychiatric disorders according
to mesial temporal sclerosis
Patients were divided in four groups: 25 patients with right
MTS (RMTS), 30 with left MTS (LMTS), 8 with bitemporal MTS
(BMTS) and 10 without MTS (WMTS). Groups were statistically
different regarding gender (p = 0.043), as there were only two
(20%) women in theWMTS group, and according to the duration of
epilepsy (p = 0.047), as the WMTS group had also a shorter
duration of epilepsy. Therewere no other signiﬁcant differences on
sociodemographic and clinical variables as displayed in Table 3.
Patientswith LMTS had a higher frequency ofmood and anxiety
disorders, though only anxiety disorders reach statistical signiﬁ-
cance (p = 0.006)when all groupswere compared. Higher scores on
HAM-A and HAM-D (p < 0.05 in both) were also linked to LMTS
(Table 4). The group with BMTS had an eminent higher frequency
of psychosis (25%) when compared to the other groups (<5%),
though this difference did not reach statistical signiﬁcance
(p = 0.14), as shown in Table 4. In addition, both groups with
BMTS and LMTS presented high scores in BPRS (p = 0.06).
4. Discussion
This study describes a cross-sectional observation of the
neuropsychiatric proﬁle of patients with TLE seen in a tertiary-
care service. The assessment of mental state in epilepsy should
consider that the internationally accepted systems of classiﬁcation
in psychiatry, ICD-10 and DSM-IV, tend to label the neuropsychi-
atric comorbidities in epilepsy as ‘‘organic’’ or ‘‘due to medicaloral sclerosis.
S (n=30) BMTS (n=8) WMTS (n=10) p-Value
p=0.043*
70%) 4 (50%) 2 (20%)
(8.7) 39.7 (11.7) 40.2 (12.3) n.s.**
n.s.*
31%) 6 (75%) 5 (50%)
n.s.*
50%) 1 (12.5%) 3 (30%)
n.s.*
40%) 5 (65.5%) 2 (20%)
33.3%) 3 (37.5%) 6 (60%) n.s.*
93.3%) 8 (100%) 10 (100%) n.s.*
43.3%) 4 (50%) 5 (50%) n.s.*
(11.2) 34.4 (12.5) 22.2 (17.3) p=0.047**
(3.1) 6.3 (10.8) 5.2 (9.1) n.s.**
83.3%) 5 (62.5%) 8 (80%) n.s.*
6.7%) 1 (12.5%) 1 (10%) n.s.*
(0.5) 2.4 (0.5) 2.0 (0.5) n.s.**
10%) 0 1 (10%) n.s.*
l sclerosis; BMTS, bilateral MTS; SD, standard deviation; AEDs, antiepileptic drugs.
Table 4
Neuropsychiatric characteristics according to mesial temporal sclerosis.
Total (n=73)
RMTS (n=25) LMTS (n=30) BMTS (n=8) WMTS (n=10) p-Value
Mood disorder 8 (32%) 19 (63.3%) 4 (50%) 4 (40%) n.s.*
Anxiety disorder 6 (24%) 20 (66.7%) 2 (25%) 3 (30%) p=0.006*
Psychotic disorder 1 (4%) 1 (3.3%) 2 (25%) 0 p=0.141*
Somatoform disorder 3 (12%) 5 (16.7%) 1 (12.5%) 1 (10%) n.s.*
Substance-related disorder 0 1 (3.3%) 0 1 (10%) n.s.*
HAM-D; mean (SD) 11.1 (8.8) 20.6 (12) 16.4 (11.4) 15.8 (12.7) p=0.034**
HAM-A; mean (SD) 7.5 (6) 14.4 (9.2) 9 (7.3) 10.2 (9.5) p=0.022**
BPRS; mean (SD) 8.4 (10) 13.1 (9.5) 12 (11.3) 8.4 (8) p=0.060**
WMTS, without MTS; RMTS, right mesial temporal sclerosis; LMTS, left mesial temporal sclerosis; BMTS, bilateral MTS; SD, standard deviation.
* Fisher’s Exact test.
** Kruskal–Wallis test.
G.N.M. de Oliveira et al. / Seizure 19 (2010) 479–484482conditions’’. However, most experts on this subject agree that such
systems are clearly superﬁcial and overlook the neuropsychiatry
diversity found in epilepsy.32,33 For this reason, the present study
addresses the recent proposal by the ILAE Commission on
Psychobiology of Epilepsy33,34 since the diagnosis was based in
a psychopathological description that also tried to consider clinical
variables related to epilepsy.
The population in the study consisted of relatively young
patients, with childhood onset seizures, without complete remis-
sion despite the fact that the majority of patients was taking more
than one AED. In these patients, TLE compromised signiﬁcantly
labour functioning as a large number of individuals were receiving
illness welfare beneﬁts.
The present study highlights the high frequency of lifetime
mental disorders in TLE, especially depression and anxiety. It is
worth pointing out that it is not unusual to see the coexistence of
mood and anxiety disorders in the same individual, with or
without epilepsy.3 Depression is considered the most common
mental disorder in people with epilepsy,35 as is evidenced in this
sample, where more than one-third of patients had a major
depressive disorder during their lives and a signiﬁcant number of
patients were depressed when evaluated. These data show an
increase in prevalence of major depression or any mood disorder
over the general population without epilepsy, whose lifetime
prevalence rates are around 11% and 13%, respectively.4
The underdiagnosis and undertreatment of depression
highlighted by this study are not new in literature, but underline
its persistence despite several warnings from specialists on the
topic.3,32,36 We can infer from the results that none of the
evaluated patients with current major depression were receiving
psychiatric treatment. The only patient taking antidepressants was
actually being treated for migraine (25 mg amitriptyline), whose
therapeutic dose is below that recommended for depression,37 and
still showed signiﬁcant depressive symptoms.
Most studies evaluating mood disorders in epilepsy focus on
depressive disorders and information regarding bipolar disorder
(BD) in this population is still limited.38 BDwas diagnosed in about
10% of the patients, which is consistent with a recent publication
that found BD in 11.8% of a total of 143 epileptic patients, most of
them with TLE.23 However, these authors draw attention to the
role of Interictal Dysphoric Disorder (IDD), AEDs and perictal
phenomena producing phenotypic copies of BD.39 By removing
these confounding factors, the authors describe a frequency of 1.4%
of ‘‘pure bipolar’’, arguing that the ‘‘pure’’ BD frequency in epilepsy
is similar to the one found in general population.23 Although some
patients have reported perictal manic and hypomanic episodes in
the present study, this information has limited value because self-
reports are often inaccurate due to common memory impairment
and this is one of the limitations of this cross-sectional study. One
proposal would include a more detailed longitudinal assessment
with seizure and mood calendars.23Anxiety and depression have close overlap in clinical prac-
tice40,41 which might reﬂect common pathogenic mechanisms
shared with epilepsy comprising limbic structures.22,42,43 Tebartz
van Elst et al.44 described increased amygdala volume in TLE
patients with dysthymia and additionally pointed out that
depressive symptoms positively correlated to the left amygdala
volume.44,45 A greater volume of the right amygdala was reported
in a group of eight patients with partial refractory epilepsy and
comorbid anxietywhen compared to a group of eight patients with
epilepsy but no psychopathology.46 Paparrigopoulos et al.43
analyzed mesial structures volume after lobectomy for epilepsy
and observed that right side hippocampus volumes positively
correlated to depressive symptoms in patients who underwent
left-side resections and that anxiety symptoms were negatively
correlated to the residual left hippocampal volume. They
hypothesized that right–left hippocampal asymmetry can inﬂu-
ence mood regulation yielding higher rates of depressive and
anxiety symptoms, at least in LMTS.43
Interestingly, Bear and Fedio47 described that patients with left
TLE tended to exaggerate their depressive complaints on self-
reports while patients with right TLE minimized them. Altshuler
et al.48 also found that patients with left TLE scored higher on self-
ratings for depression. It is possible that a personality traitmay be a
confounding factor but this was minimized as the psychopatho-
logical assessment used here was based on observer-rated
instruments. In the present study, the diagnosis of anxiety
disorders were more likely to occur in patients with LMTS
(p = 0.006) that also had higher scores on HAM-A (p = 0.012) and
on HAM-D (p = 0.03) too. These data are in line with the literature
that reports that anxiety disorders are associated with functional
impairment in left limbic structures49–51 that can also be linked to
the coexistence of depressive symptoms.48,49 However, the
etiology of mental disorders in epilepsy is probably multifactorial
in which neurobiological and psychosocial variables interact. In
this direction, it should be commented that the groups with MTS,
especially LMTS, where the ones with lengthier disease. Long
duration epilepsy may be associated with constant uncertainty
created by refractory seizures, fear and social restriction which are
psychosocial risk factors for anxiety disorders.46 Additionally,
limbic structures are associated with the genesis of epilepsy,
anxiety and depression what makes this association also relevant
from a neurobiological perspective.3,40 On the other hand, studies
have shown that a shorter duration of epilepsywas associatedwith
depression52,53 and other psychiatric conditions, emphasizing the
difﬁculties of coping with a new medical problem.54 Hence, it
seems appropriate to consider the duration of seizure disorder
when interpreting psychiatric comorbidity in epilepsy.
Psychotic disorders were diagnosed in 5.5% of the sample, a
percentage lower than that described in the literature which
suggests that the prevalence of psychosis in TLE is around
19%.13,16,55 The explanations for this may include methodological
G.N.M. de Oliveira et al. / Seizure 19 (2010) 479–484 483differences, outpatients proﬁle and the sample size. It is also
possible that some psychotic patients were excluded due to low
MMSE scores as often psychotic syndromes are associated with
severe cognitive impairments.56
The discussion around laterality and psychotic manifestations
was inaugurated by the seminal work of Flor-Henry.57 He used
data from the Maudsley archives to compare 50 TLE patients with
psychotic episodes to 50 randomly selected TLE patients and found
an increased predisposition to psychosis if the dominant hemi-
sphere was affected. The involvement of bilateral cerebral
dysfunction in postictal psychosis is demonstrated by some
authors58,59 and was reinforced recently by Falip et al.60 who
analyzed 55 refractory TLE patients undergoing video-EEG
monitoring. A SPECT study by Leutmezer et al.61 described
bifrontal and bitemporal hyperactivation during postictal psy-
chotic states in patients with TLE. Umbricht et al.55 found a greater
rate of bitemporal foci not only among TLE patients with postictal
psychosis but also those with chronic psychoses, suggesting that
both psychotic variants are possibly etiologically related. Interest-
ing MRI ﬁndings by Bogerts et al.,62 who evaluated temporolimbic
structural abnormalities in schizophrenia, indicate a link between
bilateral hippocampal atrophy to a more severe and refractory
psychosis. In the present study, though not statistically signiﬁcant,
it is possible to discern an increased frequency of psychotic
disorders in the BMTS group in agreement with the aforemen-
tioned studies that support a bitemporal involvement in psychosis.
The present study has some clear limitations, such as the
sample size consisting of severely ill patients and also the lack of
control groups. Conversely, an important strength of this study is
the broad psychiatric assessment which allows accurate psycho-
pathological description.
Future research must contemplate follow-up studies attentive
to treatment and prognosis. As most of the studies were conducted
in specialized centers, primary care studies in developing countries
are needed to show the current status of the problem in the
community as well. Another important point to investigate is the
outcome of the patients who will undergo epilepsy surgery.
Moreover, forthcoming studies shall take into account the ILAE
recommendations on the diagnosis ofmental disorders in epilepsy.
Considering these observations, the present study can encourage
proposals to include speciﬁc classiﬁcation of epilepsy mental
disorders on the newer versions of psychiatricmanuals, such as the
DSM-5, which is being formulated.
Finally, it is also possible that there was an overdiagnosis of
anxiety, bipolar and OCD due to the psychopathological instru-
ments used here, as there is no gold standard assessment
instrument to neuropsychiatric diagnosis in epilepsy. On the other
hand, the methods used in the present study are consistent to the
ones proposed by ILAE experts and have practical implications as a
reference for clinical interventions.24,33 In any event, in trying to
improve epilepsy treatment and quality of life it is important to
listen carefully to the patients complaints and not only diagnose
but also treat properly psychiatric comorbidities. Kanner63 argues
that patients should be referred for psychiatric treatment as if the
following are suspected: a diagnosis of bipolar disorder, depression
with psychotic symptoms, any mood disorder with suicidal
ideation or major depression that persists after two trials of
antidepressants.
5. Conclusion
More efforts are needed in order to improve recognition of
neuropsychiatric comorbidity and its treatment. Psychiatric
disorders are commonly neglected in epilepsy and new clinical
instruments may help elucidating psychopathological features
commonly described in the epilepsy context. Patients with LMTSare more susceptible to psychiatric conditions, such as anxiety
disorders, while psychosis may show a special correlation with
bilateral damage in mesial temporal lobes.
The investigation of the neuropsychiatric aspects of TLE should
direct the development of programs to improve the management
of the common mental disorders that accompany this epileptic
syndrome. Therefore, we hope that this study contributes to the
discussion and reinforces the need to identify what often goes
unnoticed in many TLE patients with mental disorders in Brazil.
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